341125 <common-name>9-(2-chlorophenyl)-n-(2,3-dichlorophenyl)-3-methyl-17-thia-2,4,5,8,14-pentazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,8,11(16)-pentaene-14-carboxamide</common-name> <description>9-(2-chlorophenyl)-n-(2,3-dichlorophenyl)-3-methyl-17-thia-2,4,5,8,14-pentazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,8,11(16)-pentaene-14-carboxamide is a compound with the formula C25H19Cl3N6OS. With an average molecular weight of 557.90 g/mol, 9-(2-chlorophenyl)-n-(2,3-dichlorophenyl)-3-methyl-17-thia-2,4,5,8,14-pentazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,8,11(16)-pentaene-14-carboxamide is a heavy molecule.</description> <cas>132418-46-3</cas> <pubchem-id>3076783</pubchem-id> <chemical-formula>C25H19Cl3N6OS</chemical-formula> <weight>557.9</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T01:16:59Z</created-at> <updated-at type="dateTime">2026-08-31T01:16:59Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=NN=C2N1C3=C(C4=C(S3)CN(CC4)C(=O)NC5=C(C(=CC=C5)Cl)Cl)C(=NC2)C6=CC=CC=C6Cl</moldb-smiles> <moldb-formula>C25H19Cl3N6OS</moldb-formula> <moldb-inchi>InChI=1S/C25H19Cl3N6OS/c1-13-31-32-20-11-29-23(14-5-2-3-6-16(14)26)21-15-9-10-33(12-19(15)36-24(21)34(13)20)25(35)30-18-8-4-7-17(27)22(18)28/h2-8H,9-12H2,1H3,(H,30,35)</moldb-inchi> <moldb-inchikey>XQTNMWVPAYTWIA-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">556.040664</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM337018</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>9-(2-chlorophenyl)-n-(2,3-dichlorophenyl)-3-methyl-17-thia-2,4,5,8,14-pentazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,8,11(16)-pentaene-14-carboxamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Thienodiazepines</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0291523</sync-id> <structure-inchikey>XQTNMWVPAYTWIA-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>20000000001000000000000100000020800000000000200000000000000000000000000080000080428120000000000400000000400400000000000000000000004000000000000000800000200000100000000000080000000000000000000110010000000000010040000000040201000000000202800000100000010000c00000008000000000000000800800000001000000800000000004000000000000000000000800400c00000000000000000000000080000000000000800000000000000000000000000008000000140084008020022012000000000000000080000100000000c0000000000400000020000000000040004000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAKQAAAIABBgBgAAAAAQMGQCgAAAAD BAdAKAAAAAMDB0AoAAAAAwMGQCgAAAADBAdAKAAAAAMDBkAoAAAAAwQGQCgA AAADBAZAKAAAAAMEBkAoAAAAAwQQQCgAAAADAgYAYAAAAAICBwAoAAAAAwMG AGAAAAACAgYAYAAAAAICBgAoAAAAAwQIACgAAAADAgcAaAAAAAMCAQZAKAAA AAMEBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMD AREAIAAAAAERACAAAAABBgAoAAAAAwQHACgAAAADAwYAYAAAAAICBkAoAAAA AwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgAAAAD BBEAIAAAAAELAAEAAQJoDAIDaAwDBGgMBAVoDAUGIAYHaAwHCGgMCAloDAkK aAwJCwALDAAMDQANDgAMDyAPECgCDxEgERIgEhNoDBMUaAwUFWgMFRZoDBYX aAwUGAATGQAHGiAaGygCGxwAGh0gHR5oDB4faAwfIGgMICFoDCEiaAwiIwAF AWgMHAQACgZoDA4IABcSaAwiHWgMQgYAAAAFAQIDBAUFCgkIBwYGCwwNDggJ BhMUFRYXEgcbGgcGBQQcBh4fICEiHRcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:41:10Z</structure-indexed-at> </compound>